RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        In situ gel of lamotrigine for augmented brain delivery: development characterization and pharmacokinetic evaluation

        Poonam Parashar,Naresh Diwaker,Jovita Kanoujia,Mahendra Singh,Abhishek Yadav,Indu Singh,Shubhini A. Saraf 한국약제학회 2020 Journal of Pharmaceutical Investigation Vol.50 No.1

        Purpose Treatment of epilepsy faces immense challenge and often fails due to pharmaco-resistance and incapability of antiepileptic drug to cross the blood brain barrier (BBB). This problem demands an alternate, newer effective delivery approach. The intranasal drug delivery has emerged as a preferential route because of its ability to deliver drug directly to brain, facilitated through unique anatomy of the nasal cavity. The purpose of present study was to formulate and characterize in situ gel of lamotrigine (LGT) for delivery via nasal route. Methods The in situ gel was prepared using cold method utilizing sodium alginate, chitosan and methyl cellulose. The in vitro characterization of gel was performed for pH, gelation, drug content, viscosity, gel strength, in vitro release, and mucoadhesive strength. Results The clear in situ gel consisting of sodium alginate (0.05% w/v) and chitosan (0.25% w/v), showed 76.05% drug release in 8 h with pH 5.30 ± 0.07, drug content 94.93% and gel strength 46.00 ± 2.00 s. Further, the optimized (IG8) formulation was subjected for ex vivo permeation study and histopathological analysis. The amount of LGT in brain and plasma was determined pharmacokinetically in rat model. An enhanced brain concentration (200% approximately) of LGT was achieved (AUC last 9.33 ± 2.54 μg h/mL, Cmax 1.41 ± 0.15 μg/mL) in case of in situ gel when compared with oral drug suspension (AUC last 4.78 ± 1.98 mcg h/mL, Cmax 0.84 ± 0.28 μg/mL). Conclusion In situ gel of LGT via intranasal route can be taken as a viable alternative to the conventional antiepileptic drug delivery.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼